These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Randomized trials in hemodialysis patients: time to step up to the plate. Tonelli M JAMA; 2008 May; 299(18):2205-7. PubMed ID: 18477790 [No Abstract] [Full Text] [Related]
46. Spontaneous bypass of a haemodialysis return vein stenosis. Cini A; Galan A; Piquet P J Med Vasc; 2022 Oct; 47(4):207-209. PubMed ID: 36344034 [No Abstract] [Full Text] [Related]
47. First Clinical Results of the Merit WRAPSODY™ Cell-Impermeable Endoprosthesis for Treatment of Access Circuit Stenosis in Haemodialysis Patients. Gilbert J; Rai J; Kingsmore D; Skousen J; Ptohis N Cardiovasc Intervent Radiol; 2021 Dec; 44(12):1916-1917. PubMed ID: 34755199 [No Abstract] [Full Text] [Related]
48. Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia--a review. Clowes AW; Reidy MA J Vasc Surg; 1991 Jun; 13(6):885-91. PubMed ID: 2038110 [No Abstract] [Full Text] [Related]
49. Access for acute haemodialysis: a unique, pulse preserving shunt. Ross AH; Eke N; Jenkins AM Br J Surg; 1987 Apr; 74(4):251. PubMed ID: 3580794 [No Abstract] [Full Text] [Related]
50. Meta-analysis and commentary: Preemptive correction of arteriovenous access stenosis. Raimann JG; Waldron L; Koh E; Miller GA; Sor MH; Gray RJ; Kotanko P Hemodial Int; 2018 Apr; 22(2):279-280. PubMed ID: 28972691 [No Abstract] [Full Text] [Related]
51. Intervention for intra-access stenosis. Besarab A Semin Dial; 2001; 14(5):401-2. PubMed ID: 11679113 [No Abstract] [Full Text] [Related]
52. Survival in haemodialysis: is there a role for vascular access? de Almeida E; Dias L; de Sousa FT; Mil-Homens MC; Pataca I; Prata MM Nephrol Dial Transplant; 1997 Apr; 12(4):852. PubMed ID: 9141036 [No Abstract] [Full Text] [Related]
53. Letter to the Editor Regarding "First Clinical Results of the Merit WRAPSODY Cell-Impermeable Endoprosthesis for Treatment of Access Circuit Stenosis in Haemodialysis Patients" published by Gilbert et al. Bream PR; Chick JFB; Lessne ML Cardiovasc Intervent Radiol; 2021 Dec; 44(12):1914-1915. PubMed ID: 34708265 [No Abstract] [Full Text] [Related]
54. Quinoxalines versus indolinones as inhibitors of restenosis. Levitzki A Circ Res; 2001 Jun; 88(12):E77-7. PubMed ID: 11420309 [No Abstract] [Full Text] [Related]
55. Suppression of neointimal hyperplasia by sirolimus-eluting expanded polytetrafluoroethylene (ePTFE) haemodialysis grafts in comparison with paclitaxel-coated grafts. Baek I; Bai CZ; Hwang J; Park J; Park JS; Kim DJ Nephrol Dial Transplant; 2012 May; 27(5):1997-2004. PubMed ID: 22058173 [TBL] [Abstract][Full Text] [Related]
57. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis. Lee BH; Nam HY; Kwon T; Kim SJ; Kwon GY; Jeon HJ; Lim HJ; Lee WK; Park JS; Ko JY; Kim DJ Nephrol Dial Transplant; 2006 Sep; 21(9):2432-8. PubMed ID: 16554328 [TBL] [Abstract][Full Text] [Related]
58. Contemporary vascular access surgery for chronic haemodialysis. Koo Seen Lin LC; Burnapp L J R Coll Surg Edinb; 1996 Jun; 41(3):164-9. PubMed ID: 8763179 [TBL] [Abstract][Full Text] [Related]
59. Paclitaxel - a tool to prevent stenosis in vascular access for haemodialysis? Konner K Blood Purif; 2006; 24(3):287-8. PubMed ID: 16465048 [No Abstract] [Full Text] [Related]